Mark S Schroeder Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 20 hours ago
Mark S Schroeder has an estimated net worth of at least $10.4 million*, as of April 1, 2026. They own 12,677 shares of LH stock. They have sold 29,982 shares of LH stock since 2021, for an estimated $7.0 million.
Mark S Schroeder $LH SEC Form 4 Insider Trading
Mark S Schroeder has filed a total of 14 insider trades in $LH since 2021. Their most recent trade was a sale of 2,635 shares, made on Mar 28, 2025. Their largest trade was a sale of 6,477 shares, made on Apr 01, 2024. We estimate that they now own 12,677 shares of $LH, worth an estimated $3.4 million.
Insider Trading at $LH
There have been a total of 110 insider trades reported at $LH since 2021, with 3,586 shares purchased and 298,986 shares sold. The most active insider traders in $LH stock have been Der Vaart Sandra D Van, Glenn A Eisenberg, and Peter J Wilkinson. The most recent trade was a sale of 1,633 shares reported by Peter J Wilkinson (SVP, Chief Accounting Officer), made on Mar 27, 2026.
History of Insider Stock Trades by Mark S Schroeder
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
LH
|
Sale | 2,635 | Mar 28, 2025 | March 31, 2025, 10:39 a.m. |
|
LH
|
Sale | 5,339 | Feb 28, 2025 | March 4, 2025, 9:41 a.m. |
|
LH
|
Sale | 6,477 | Apr 01, 2024 | April 3, 2024, 8:35 a.m. |
|
LH
|
Sale | 5,048 | Mar 07, 2024 | March 11, 2024, 8:59 a.m. |
|
LH
|
Sale | 1,500 | May 18, 2023 | May 22, 2023, 3:08 p.m. |
|
LH
|
Sale | 3,897 | Mar 31, 2023 | April 3, 2023, 10:05 a.m. |
|
LH
|
Sale | 309 | Feb 14, 2023 | Feb. 16, 2023, 1:51 p.m. |
|
LH
|
Sale | 409 | Feb 07, 2023 | Feb. 9, 2023, 10:04 a.m. |
|
LH
|
Sale | 324 | Feb 03, 2023 | Feb. 6, 2023, 4:51 p.m. |
|
LH
|
Sale | 1,116 | Nov 08, 2022 | Nov. 10, 2022, 9:40 a.m. |
|
LH
|
Sale | 2,356 | Mar 29, 2022 | March 31, 2022, 10:24 a.m. |
|
LH
|
Sale | 207 | Feb 15, 2022 | Feb. 17, 2022, 4:05 p.m. |
|
LH
|
Sale | 204 | Feb 07, 2022 | Feb. 8, 2022, 12:08 p.m. |
|
LH
|
Sale | 161 | Feb 03, 2022 | Feb. 4, 2022, 1:15 p.m. |
$LH Executives and Stock Owners with Insider Trades
-
Der Vaart Sandra D Van, EVP, Chief Legal Officer
-
Glenn A Eisenberg, Chief Financial Officer, EVP
-
Peter J Wilkinson, SVP, Chief Accounting Officer
-
Mark S Schroeder, EVP, President-Diagnostics Lab
-
Adam H Schechter, President & CEO
-
Amy B. Summy, EVP, Chief Marketing Officer
-
Mark S Schroeder, EVP, Pres Diagnostics & COO
-
Jonathan C Meltzer, EVP, Operations
-
Brian J Caveney, EVP, Pres of ED, CMO & CSO
-
Brian J Caveney, EVP, President of Diagnostics
-
Lance Berberian, EVP, CIO & CTO
-
Paul R Kirchgraber, CEO, Covance Drug Development
-
Glenn A Eisenberg, Executive Vice President
-
Jonathan P. Divincenzo, EVP, Pres, Central Labs & Intl
-
Der Vaart Sandra D Van, EVP, Corporate Affairs
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.